seeing, hearing, or feeling things that are not there
Sep 14, 2020 · Tolterodine tartrate tablets for oral administration contain 1 or 2 mg of tolterodine tartrate
The partition coefficient (Log D) between n-octanol and water is 1
Prescribing and dispensing information The need for continuing therapy for urinary incontinence should be reviewed every 4–6 weeks until symptoms stabilise, and then every 6–12 months
Generic name: tolterodine [ tol-TER-oh-deen ] Brand names: Detrol, Detrol LA
See more Tolterodine TARTRATE Tolterodine TARTRATE - Uses, Side Effects, and More Common Brand (S): Detrol Generic Name (S): tolterodine Uses This medication is used to treat
Your doctor may adjust your dose if needed
stuffy or runny nose sweating tightness of the chest or wheezing trouble with sleeping vomiting Incidence not known Being forgetful bloating or swelling of the face
Key facts You’ll usually take tolterodine tablets twice a day or slow-release capsules once a day
Tolterodine tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency
The inactive ingredients are colloidal anhydrous silica, calcium hydrogen phosphate
The inactive ingredients are colloidal anhydrous silica, calcium hydrogen
Dry mouth, dry eyes, headache, constipation, stomach upset/pain, dizziness, drowsiness, tiredness, or blurred vision may occur
The dose may be lowered to 2 mg daily based on 3 DOSAGE FORMS AND STRENGTHS
For oral dosage form (extended-release capsules): Adults—4 milligrams (mg) once a day
The inactive ingredients are colloidal silicone dioxide, dibasic calcium phosphate dihydrate, cellulose microcrystalline, magnesium stearate, sodium starch glycolate (pH 3
The tablets are for oral use and should be swallowed whole
Serious side effects may include angioedema, urinary retention, and QT
00, which is 86% off the average retail price of $163
The absolute bioavailability is higher in individuals with the poor-oxidizer phenotype (i
37 mg of tolterodine
Each tolterodine tartrate tablets for oral administration contains 1 or 2 mg of tolterodine tartrate
TO
The structural formula of tolterodine tartrate is represented below: Tolterodine tartrate is a white, crystalline powder
Pharmacology Management: Reduce tolterodine dose to 1 mg twice daily (regular release formulation) or 2 mg daily (extended release formulation) (adult doses) and monitor for increased levels/effects of tolterodine with initiation of vinblastine therapy
0 to 5
5 Interaction with other medicinal products and other forms of interaction
2 mg; 4 mg; Dosage Considerations – Should be Given as Follows AS LOW AS $112
Unit tablet
Tolterodine Tartrate 1 mg Film-Coated Tablets (Pfizer Limited)